CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Paradigm Capital

Paradigm Capital Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Quantum Intech (QI)

Quantum Intech (QI) is a Boulder Creek, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

STRIDE Fitness

STRIDE Fitness is a heart-rate-based total body HIIT workout accessible for all. Combining interval training, endurance-based training, and strength training in a unique program format designed for both walkers and runners.

Physicians Immediate Care

Physicians Immediate Care is a Richland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VCA Antech Inc.

VCA Antech, Inc. (VCA) is an animal healthcare company operating in the United States and Canada.